In order to make structural heart procedures more predictable, computational modeling is likely to have a critical role to play. FEops have successfully developed technology that simulates the interaction between implanted devices and various cardiac structures. We view this as a very exiting development in interventional cardiology.
Pre-operatively simulating different scenarios of the intervention will undoubtedly play a key role in further reducing complications for structural heart interventions.
In order to make structural heart procedures more predictable, computational modeling is likely to have a critical role to play. FEops have successfully developed technology that simulates the interaction between implanted devices and various cardiac structures. We view this as a very exiting development in interventional cardiology.”
FEops are leading the way in image segmentation and computer modelling. With an emphasis on structural intervention, new solutions are being developed to enable clinicians to better plan for their procedures and to predict outcomes more robustly than historical geometric data alone.
We created the Computer Modeling and Simulation Project to achieve the delivery of medical product solutions in a responsible, patient-sparing way that balances the desire for certainty in through the use of computer modeling and simulation as valid scientific evidence.”
Office of Science and Engineering Laboratories, Center of Devices and Radiological Health, US Food and Drug administration.
The FDA wants to advance the use of computational modeling and simulation for medical devices and supports the development of virtual physiological patients, clinical trial simulations and personalized medicine.”
Ideally, as TAVI becomes standard of care even in low and intermediate risk patients, it would be great to take the guess-work out – to be able to simulate what is going to happen when you put the valve into that anatomy.
FEops HEARTguide gives our team increased confidence to perform TAVI in the most challenging of aortic valve anatomies
I have the strong hope and believe that preprocedural planning with FEops HEARTguide will transform percutaneous LAA closure into an even more safe and more efficient procedure for patients with non-valvular atrial fibrillation and contraindications for oral anticoagulant therapy.